Phase II study of fulvestrant 250 mg/month in patients with recurrent or metastatic endometrial cancer: A study of the Arbeitsgemeinschaft Gynäkologische Onkologie
| Autor: | Emons, Günter, Günthert, Andreas, Thiel, Falk C., Camara, Oumar, Strauss, Hans-Georg, Breitbach, Georg-Peter, Kölbl, Heinz, Reimer, Toralf, Finas, Dominique, Rensing, Klaus |
|---|---|
| Zdroj: | In Gynecologic Oncology June 2013 129(3):495-499 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect